ArticleAlzheimer's & dementia (New York, N. Y.)2022

Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.

Adam C Raikes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.